Neuroprotective Effects of Tetramethylpyrazine in Cerebral Ischemia

Tetramethylpyrazine (TMP), an alkaloid extracted from Ligusticum chuanxiong, has emerged as a promising intervention for cerebral ischaemia through multiple complementary mechanisms. In experimental stroke models, TMP preserves neuronal viability by attenuating oxidative stress, suppressing pro-inflammatory cytokine release and inhibiting apoptosis. It stabilises the blood–brain barrier and maintains neurovascular unit integrity, thereby reducing cerebral oedema and limiting infarct expansion. TMP also promotes endogenous repair by enhancing angiogenesis and neurogenesis, and by modulating astrocytic phenotypes to support tissue recovery. Preclinical studies demonstrate that TMP penetrates the central nervous system, modulates key signalling pathways—including PI3K/AKT and MAPK cascades—and influences mitochondrial function to improve energy homeostasis. Collectively, these properties underpin TMP’s capacity to mitigate neuronal injury, accelerate functional recovery and offer translational potential for adjunctive therapy in acute ischaemic stroke.

Research from Nature Portfolio

Recent studies have explored a novel TMP derivative bearing a nitrone moiety that enhances free-radical scavenging and improves pharmacokinetics. In a non-human primate model of middle cerebral artery occlusion, this compound readily crossed the blood–brain barrier and achieved therapeutic concentrations. Treated animals exhibited significantly reduced infarct volumes on MRI and modest preservation of limb function over four weeks. Quantitative proteomic analyses revealed down-regulation of neuroinflammatory markers and glial fibrillary acidic protein, along with restoration of myelination-associated proteins and increased neuronal survival in peri-infarct regions. These findings support the derivative’s multifunctional profile and highlight its promise as a clinical candidate for ischaemic stroke.

Neuroprotective Effects of Tetramethylpyrazine in Cerebral Ischemia publication trend

The graph below shows the total number of articles in neuroprotective effects of tetramethylpyrazine in cerebral ischemia across all publications each year (not limited to Nature Index journals).

Technical terms

Tetramethylpyrazine (TMP): A small organic alkaloid derived from traditional Chinese medicine with antioxidant, anti-inflammatory and vasodilatory properties.

Blood–brain barrier (BBB): A selective interface of endothelial cells that regulates transport between the bloodstream and neural tissue, crucial for maintaining central nervous system homeostasis.

Neurovascular unit (NVU): The functional ensemble of neurons, glia, endothelial cells and extracellular matrix that governs cerebral blood flow and supports neuronal health.

Reactive astrocytes (A1/A2): Subtypes of astroglial cells that adopt pro-inflammatory (A1) or reparative (A2) phenotypes in response to injury, influencing neuroinflammation and repair.

Apoptosis: Programmed cell death characterised by energy-dependent cellular dismantling, which contributes to tissue loss after ischaemic injury.

Oxidative stress: An imbalance between reactive oxygen species production and antioxidant defences, leading to cell damage in ischaemic brain tissue.

References

1. The protective effects of ligustrazine on ischemic stroke: a systematic review and meta-analysis of preclinical evidence and possible mechanisms. Frontiers in Pharmacology (2024).
2. Tetramethylpyrazine promotes stroke recovery by inducing the restoration of neurovascular unit and transformation of A1/A2 reactive astrocytes. Frontiers in Cellular Neuroscience (2023).
3. Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy. Scientific Reports (2016).
4. Tetramethylpyrazine: A review on its mechanisms and functions. Biomedicine & Pharmacotherapy (2022).